Bli medlem
Bli medlem

Du är här


Invitation to presentation of Q-linea’s Interim report Q2-2021 on July 15, 2021

Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), to publish the company’s interim report for the period January – June 2021 on Thursday July 15, 2021 at 07:30 a.m. CEST.

Q-linea invites to an audiocast with teleconference (in English) for investors, analysts and media on July 15, 2021, at 13:00 – 14:00 p.m (CEST).

Jonas Jarvius, CEO, and Anders Lundin, CFO, to present Q-linea and comment on the interim report followed by a Q&A-session.

To participate, please call any of the following phone numbers from:
SE: +46 8 566 426 95
UK: +44 333 300 9265
US +1 646 722 4956


For further information, please contact:

Anders Lundin, CFO and IR
Telephone: +46 706 00 15 20

About Q-linea

Q-linea is an innovative infection diagnostics company that primarily develops instruments and disposables for rapid and reliable infection diagnostics. Our vision is to help save lives by ensuring antibiotics continue to be an effective treatment for future generations. Q-linea develops and delivers preferred solutions for healthcare providers, enabling them to accurately diagnose and treat infectious disease in the shortest possible time. The company's lead product ASTar® is a fully automated instrument for antibiotic susceptibility testing (AST), giving a susceptibility profile within six hours directly from a positive blood culture. For more information, please visit


Invitation to presentation of Q-linea’s Interim report Q2-2021 on July 15, 2021

Författare MFN

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.